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Abstract 
Introduction: Coronavirus has spread rapidly in Pakistan. These patients were kept at quarantine facilities on 
suspicion, even before RT-PCR was done. We were able to collect clinical, laboratory, and management features 
from them.   
Objective: To assess the features of Corona confirmed and unconfirmed patients, and compare them. It could 
help in deciding if confirmed and unconfirmed patients were correctly identified and managed appropriately. 
Material and Methods: Retrospective, Descriptive, Crossectional study between 8th April to 30th April 2020. 
Patient data was collected from different sites retrospectively, on a Performa. Clinical, Laboratory, and 
Management data as collected. It was analyzed on SPSS 23. All patients in quarantines and ICU were included, 
irrespective of their corona PCR status, if the treating physicians had a strong suspicion. Home quarantine and 
less than 15-year old patients were excluded.  
Results: Clinical features showed more preponderance for males and smokers. Chronic disease patients were also 
significantly involved. Fatigue, nasal congestion, runny nose, sickness, and vomiting were more common in 
confirmed patients. CURB 65 scores 3 and 4 were more in unconfirmed patients. CT involvement was more 
common in unconfirmed patients as was high white cells and neutrophils. More patients had mechanical 
ventilation in the unconfirmed group, and they also had more secondary infections and shock. Antibiotic use was 
more common in the confirmed group. 
Conclusion: Corona was more common in males and smokers. Though fever and cough were common, the 
presence of fatigue, runny nose, nasal congestion sickness, and vomiting discriminated confirmed patients. 
Antibiotics should be used irrespective of RT-PCR results, especially if CT showed an abnormality.  
Keywords: Coronavirus, Confirmed, Features, Fatigue, Antibiotic.  
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Introduction 
 
Since the reporting of the first case in Pakistan of 
coronavirus in February 2020, it was evident that the 
disease will spread here.1 Steps were taken to decrease 
the impact, but it was inevitable. With current positive 
cases exceeding 54000, the burden of disease was 
anticipated more here as compared to developed 
countries, due to lack of resources. Even developed 
nations were finding it difficult to address problems 
related to it.2 
Different features were already reported in studies, 
with evidence suggesting the presence of them in both 
confirmed and unconfirmed patients. Quarantine was 
a very important part of management to tackle 
spread.3 We also faced an additional problem because 
of the scarcity of testing kits for coronavirus, initially. 
Because there was a deficiency in information about 
the novel coronavirus, healthcare professionals were 
also not sure about many things, including which type 
of mask was needed for them, let alone deficiency of 
Personal protective equipment.4 There were a lot of 
patients with symptoms, who came in contact with 
health professionals and were either not tested, or 
their results came back negative. Even ARDS patients 
were reported in an emergency without test report 
availability. It emphasized the need to compare 
confirmed and unconfirmed patients. Coronavirus had 
affected global economies, and China was the only 
country, documenting positives out of it.5 Pakistan 
being a developing country, it became more important 
to identify cases clinically and decrease the burden of 
disease. 
Liu et al6 compared the clinical features of the elderly 
with middle age and young patients of Covid-19. They 
found that elderly patients had higher mortality with 
this disease. This study was on a very small number, 
and just targeted confirmed pneumonia patients. Our 
study identified the difference in features of all 
unconfirmed and confirmed patients in different age 
groups. We had different patterns of co-morbidities, 
exposure to infections, and vaccination patterns. It was 
worth including all such cases and observing in our 
setup. Cao et al7 studied case series of only 102 adult 
patients of Covid-19. They compared treatments, 
features, and laboratory results, with outcomes 
retrospectively. Our study was different from them. 
The policy adopted by relevant authorities was to 
quarantine all suspected and probable patients, before 
testing in a supervised facility, until tested negative or 
developed features warranting further observation 
despite being negative. Therefore, we had higher 
admissions of those who were later discharged as 
Corona PCR was negative. It was therefore possible 
for us to include these patients and observe their 
features in comparison with those who were tested 
positive.  
The study aimed to assess the features of Corona 
confirmed and unconfirmed patients, and compare 
them. These features included clinical, laboratory, and 
treatment features. It can help us in deciding if 
confirmed and unconfirmed patients were correctly 
identified and managed appropriately, and decrease 
mortality and burden on the resources. 
 
Material & Methods 
 
According to the policy of the government, all patients 
were kept in quarantine, having strong suspicion, at 
different designated areas in the city. After testing, 
PCR negative patients were allowed to go home. We 
collected this data in quarantine areas only, which 
were multiple. Retrospectively, the collection was 
done after Ethical Committee approval. Also, data was 
collected from patients who were admitted in different 
intensive care facilities in serious condition. They were 
confirmed as well as unconfirmed, as admission was 
in serious condition with insufficient time for testing. 
Some patients were serious but reported negative, but 
still, their clinicians were suspecting Covid-19 
strongly, and re-sampling was sent. 
Study Design: 
It was a Descriptive, Crossectional Study, with data 
collection retrospectively from 8th April to 30th April 
2020, after ERC approval.   
Included were all patients admitted in quarantine with 
suspicion, probable or confirmed, and were above the 
age of 15. Excluded were all non-admitted patients 
who were having suspicion but not meeting criteria 
for admission. We also excluded those who were in 
self-isolation at homes. 
Statistical Analysis: 
Data was divided into Continuous and Categorical 
variables. Continuous variables as mean and ranges 
and Categorical variables as numbers (percentages). A 
correlation was calculated in categorical data and P 
values in Continuous variables were determined 
through ANOVA Test. 
The statistical software package of social sciences 
(SPSS 23.0) was used for analysis and P values <0.05 
were considered significant.  
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Results 
 
Features were compared in three different tables, 
described as under: 
 
Basic Clinical Features (Table 1) 
A total of 488 patients were included. The majority 
were confirmed patients. The elderly and young and 
middle-age patients in both confirmed and 
unconfirmed groups were almost equal and 
statistically not significant. Male patients were 
predominant in the confirmed group as was smoking 
history, and females more frequent in the unconfirmed 
group. The P-value was also significant for Gender 
and smoking. There was a more frequent history of 
chronic liver disease, chronic kidney disease, ischemic 
heart disease, and cerebrovascular accidents in 
unconfirmed patients, whereas diabetes, hypertension, 
and persistent atrial fibrillation were more prevalent 
in confirmed patients. These findings were all 
statistically insignificant.  
The cough was more common in unconfirmed 
patients. Fever was equally present in both groups. 
Both these values were statistically insignificant. 
Fatigue, nasal congestion, running nose, and sickness 
and vomiting were more frequent in confirmed 
patients and these were also statistically significant. 
When CURB 65 score was applied, scores 0, 1, and 2 
were almost comparable in both groups. However, 
score 3 and 4 were more frequent in the unconfirmed 
group, but statistically insignificant. 
 
Table 1: Basic Clinical Features 
 Confirmed 
 Cases(%) 
Unconfirmed 
 Cases % 
P-Value 
Total 321 (65.8%) 167 (34.2%)  
Age    
Elderly 31 (9.7%) 21 (12.6%) 0.323 
Young & 
Middle Aged 
290 (90.3%) 146 (87.4%)  
Gender    
Male 270 (84.1%) 119 (71.3%) 0.001 
Female 51 (15.9%) 48 (28.7%)  
Smoking 
History 
126 (39.3%) 29 (17.4%) 0.000 
 
Past Medical 
History 
   
Chronic Liver 
Disease 
4 (1.3%) 3 (1.8%) 0.631 
Chronic 
Kidney 
Disease 
9 (2.8%) 9 (5.4%) 0.151 
Diabetes 40 (12.5%) 18 (10.8%) 0.579 
Hypertension 98 (30.5%) 43 (25.7%) 0.270 
Ischemic Heart 
Disease 
5 (1.6%) 7 (4.2%) 0.075 
Persistent 
Atrial 
Fibrillation 
3 (0.9%) 0 (0%) 0.211 
Cerebro-
vascular 
Accident 
2 (0.6%) 5 (3.%) 0.037 
Clinical 
Symptoms 
   
Cough & 
Sputum 
79 (24.6%) 64 (38.3%) 0.054 
Fever 269 (83.8%) 139 (83.8%) 0.873 
Fatigue 251 (78.7%) 107 (64.1%) 0.000 
Nasal 
Congestion 
153 (47.8%) 35 (21%) 0.000 
Runny Nose 162 (50.8%) 33 (19.8%)  0.000 
Sick & Vomit 86 (27%) 25 (15%) 0.003 
Curb 65 Score   0.332 
0 269 (86.5%)  143 (86.56%)  
1 29 (9.3%) 14 (8.4%)  
2 10 (3.2%) 5 (3.0%)  
3 1 (0.3%) 2 (1.2%)  
4 2 (0.6%) 3 (1.8%)  
 
Laboratory Features (Table 2) 
During hospitalization, unconfirmed patients had 
more involvement of CT scan for multiple lobe lesions, 
single lobe lesions or no involvement at all. Single lobe 
was more involved than multiple lobes and Pleural 
Effusion was more common in the confirmed group. 
The P-value was not significant. There was a 
significant number in the confirmed group where CT 
was not performed. 
In the routine blood examination, high white cell 
count, high neutrophil count, lower lymphocyte count 
and, low C-reactive protein were documented in 
unconfirmed patients. P-value was also significant in 
all, except white cell count. Hemoglobin, Platelet, and 
serum creatinine were similar in both groups.  
Table 2:   Laboratory Features               
 Confirmed 
Cases     % 
Not 
Confirmed 
Cases % 
P-
Value 
Total 321 (65.8%) 167 (34.2%) 0.475 
CT Results 
 
Multiple Lobe 
Lesion 
19 (5.9%) 11 (6.6%)  
Single Lobe 
Lesion 
25 (7.8%) 48 (28.7%)  
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Pleural Effusion 8 (2.5%) 2 (1.2%)  
Not Done 184 (57.3%) 4 (2.4%)  
None 75 (23.4%) 98 (58.7%)  
Lab Indicators at Admission 
White Blood Cell 
Count  
7.44  
(3.50-12.90) 
7.79  
(4 - 33) 
0.083 
Total White Blood 
Cell Increased 
59 (18.4%) 26 (15.6%) 0.438 
Total White Blood 
Cell Increased 
262 (81.6%) 141 (84.4%) 0.438 
Neutrophil 
proportion 
71.6 (3.20 - 
92) 
71.46 (50 - 
96) 
0.846 
Increased 
Neutrophil 
Proportion 
53 (16.5%) 90 (53.9%) <0.00
1 
Lymphocyte Ratio 26.92  
(8 - 35) 
21.68  
(7 - 76) 
<0.00
1 
Decreased 
Lymphocyte Ratio 
296 (92.2%) 157 (94.0%) 0.466 
C-Reactive protein 7.39 (2 - 35) 3.93 (0.8 -35) <0.00
1 
Hemoglobin 12.35 
(8 - 16) 
12.55 
(4.1 - 16) 
0.221 
Platelet 260.62 
(105 - 554) 
244.14 
(50 - 432) 
0.005 
Serum Creatinine 28.72 
(12 - 85) 
30.53  
(13 - 87) 
0.025 
 
Management Features (Table 3) 
It was observed that there were more patients with 
Invasive ventilation in the unconfirmed group. The 
confirmed group had more non-invasive ventilation. 
P-value was not significant here. There were less 
Discharged and Healed patients in the unconfirmed 
group, as was more frequent death in this group. The 
P-value was not significant. Acute Kidney Injury, 
Secondary Infection, and Shock were more frequent in 
the unconfirmed group, whereas ARDS, Acute Heart 
Injury was more frequent in the confirmed group. The 
P-value of only Secondary Infection was significant in 
favour of unconfirmed patients. Patients in both 
groups were treated symptomatically equally, but the 
antibiotic use was more frequent in the confirmed 
patient. Chloroquine or Hydroxychloroquine use was 
more frequent in the unconfirmed group. The P-value 
was again not significant. 
 
 
 
Table 3:   Management Features  
 Confirmed 
Cases     % 
Unconfirm
ed Cases % 
P-
Value 
Total 321 (65.8%) 167 (34.2%)  
Comorbidities  
Acute Respiratory 
Distress Syndrome 
(ARDS) 
24 (7.5%) 5 (3.0%) 0.115 
Acute Heart Injury 1 (0.3%) 0 (0%) 0.470 
Acute Liver Injury 0 (0%) 0 (0%) - 
Acute Kidney 
Injury 
5 (1.6%) 8 (4.8%) 0.036 
Secondary Infection 4 (1.3%) 9 (5.4%) 0.007 
Shock 3 (0.9%) 3 (1.8%) 0.413 
Treatment Given 
Symptomatic 285 (88.8%) 149 (89.2%) 0.12 
Antibiotic 35 (10.9%) 11 (6.6%) 
Chloroquine or 
Hydroxychloroquin
e 
1 (0.3%) 3 (1.8%) 
Mechanical Ventilation 
Invasive 1 (0.4%) 3 (1.9%) 0.113 
Non-Invasive 276 (99.6%) 159 (98.1%) 
Prognosis 
Healed & 
Discharged 
318 (99.1%) 161 (96.4%) 0.038 
Death 3 (0.9%) 6 (3.6%) 
 
Discussion 
  
Comparing clinical, laboratory, and management 
feature was important in understanding this disease. 
Evidence was scarce on this virus locally, especially 
when it was already here and spreading rapidly. Guo 
et al8 had documented that adults with co-morbidities 
were more likely to be victims of this virus with an 
average age of around 58 years. An important 
observation in our study was that the young and 
middle-aged population was almost equally affected 
in both groups. Qin et al9 documented that more males 
had severe disease. Vardavas and Nikitara et al10 had 
published more severity of Covid-19 in smokers. Our 
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study also suggested similarly. The reason for male 
predominance in the confirmed group was not known 
in our population but could be postulated to our social 
circumstances, where males go out for work and were 
more exposed. The same reason could also be postul 
ated for smoking, as smokers had badly affected the 
lungs. More studies were needed to confirm these 
findings. 
Wickmann et al11 performed autopsies in patients to 
document the cause of death. They confirmed the role 
of chronic diseases, especially of the lung in their 
studies. Also, viral levels were found high in other 
organs in their study. We could not justify why few 
chronic diseases were more frequently involving 
unconfirmed group, and others like diabetes and 
hypertension more in the confirmed group. One 
possibility was that the presence of chronic disease 
affects the immune status, making them more likely to 
be involved. But why the unconfirmed group had 
more organ involvement, was not explainable. A 
possibility could be that they were affected due to 
already existent disease, or involvement due to some 
other secondary cause. Further clinical evidence is 
needed in support. Lie et al12 documented false-
negative results in their study and emphasized the 
importance of correct technique for the collection of 
the RT-PCR test. In our study, we raised a question on 
the methodology used for doing PCR for Covid-19, the 
area from where a sample was taken, competency of 
the person taking the sample, and reliability of 
laboratory. These questions could also be further 
analyzed in future studies. 
Jin et al13 documented a whole series of 
gastrointestinal and other features in patients with 
Covid-19. They concluded that some symptoms could 
also appear, other than classical symptoms outside 
china. This was also a significant finding in the 
symptomatology in our study. Although fever was the 
most common symptom in both groups, Fatigue, nasal 
congestion, running nose, sickness, and vomiting were 
more frequent in the unconfirmed group, and more 
statistically significant in the confirmed group. The 
cough was more in the unconfirmed group and 
statistically insignificant. It suggested that the 
presence of these features were a better indicator of 
corona infection. Is it a feature that was different in 
our patients? We don’t know yet, but should also be 
investigated in the future. We know from the 
literature that cough and fever appear early, whereas 
fatigue was present later in the disease, as was 
sickness and vomiting.6 It appeared that if the Covid-
19 test was negative, we should recheck, especially if 
the patient developed fatigue, runny nose, and 
sickness and vomiting.  
Chen et al14 documented the features and calculated 
MuLBSTA score for predicting mortality in severe 
pneumonia cases due to Covid-19. We used CURB 65 
score, as it was convenient for us, but it was 
unexpected finding to note high scores of 3 and 4 in 
unconfirmed patients. A possible explanation could be 
another infection, bacterial or viral, causing this 
deterioration. This was supported by high white cell 
count, high neutrophils, and low lymphocytes in this 
group. But we could not explain then, why C-reactive 
protein was low in these patients. It was therefore 
required to do more studies to confirm these findings 
in this setup. Another possibility was poor testing 
quality due to multiple reasons. 
Rothan and Byrareddy15 found that CT was more 
convincing in confirmed patients for diagnosis. We 
also found that a CT scan was an important tool to 
confirm lung findings, but we could not do it in many 
patients in this study. The reason could be the 
condition of the patient or lack of resources. However, 
to find that more unconfirmed patients had multiple 
lobes or single lobe involvement was unexpected, 
especially with single lobe more in unconfirmed 
patients. It meant that either there was another 
pathology which could not be found, or the 
unconfirmed group had a false negative result, which 
should have been rechecked. It was also a different 
finding and suggested that further studies should be 
carried out in our setup. 
Misra et al16 published in Rheumatological patients 
that cytokine storm in Covid-19 patients can cause 
susceptibility to infections. They however emphasized 
that immune-suppressive treatment should be 
continued. In our study, we expected that chronic 
disease patients would be more, and was documented 
as well, but why Kidney injury, Secondary infection 
and shock was more frequent in the unconfirmed 
group, was unexplained. A possible reason could be 
missing secondary infection, inappropriate treatment, 
and hydration status in this group. This was also 
suggested by documentation of less frequent antibiotic 
use in the unconfirmed group. We knew that patients 
were initially kept in quarantine before tests, but 
discharged with medication once a single Covid-19 
test was negative.  Did they took that treatment at 
home, and was that including antibiotics could not be 
confirmed in this study. We suggest more studies to 
endorse it. Yazdany and Kim et al17 documented that 
use of Chloroquine and Hydroxychloroquine should 
be restricted until sufficient data is available through 
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randomized controlled trials. They also recommended 
against prophylaxis, until the evidence is available. 
Our study findings were that there was more use of 
Chloroquine or Hydroxychloroquine in the 
unconfirmed group. Has it interfered with the Covid-
19 PCR? Was it helpful or not? We cannot say through 
this study and suggest the need to confirm it in future 
studies. We also found that death was more frequent 
in unconfirmed patients in this study. A possible 
explanation could be a secondary infection, decreased 
use of antibiotics, frequent discharge, and readmission 
once developed a serious complication. 
 
Conclusion 
  
We concluded that Covid-19 was present in both 
adults and young and middle ages in our study. Males 
were predominantly affected, as were smokers. 
Chronic disease patients were present on both 
confirmed and unconfirmed patients, but diabetics 
and hypertensive were more common in the 
confirmed group. Though cough and fever were most 
common in both groups, Fatigue, runny nose, nasal 
congestion, sickness, and vomiting if present, strongly 
favoured Covid-19 and if RT-PCR was negative, it 
should be repeated in such patients. All severely sick 
patients should receive antibiotics aggressively, 
especially if a CT scan showed pulmonary 
involvement, irrespective of the RT-PCR result. We 
could not conclude on the affectivity of Chloroquine 
or Hydroxychloroquine and suggest randomized 
controlled studies for both prophylaxis and empirical 
use.  
 
Limitations 
  
There were several limitations to our study. First, it 
was a descriptive crossectional study. It would have 
been better if a randomized control study could be 
planned in the future. Secondly, non-admitted patients 
were missed in this study. We could only gather 
information from admitted patients in quarantine. 
Another limitation was being unable to carry out all 
the acute inflammatory parameters due to a lack of 
resources.  
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